Report : US Asthma Spacers Market Forecast to 2027 - COVID-19 Impact and Country Analysis By Product (Aerochamber, Optichamber, Volumatic, and Inspirease) and Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and E-Commerce)
US Asthma Spacers Market for Aerochambers to Grow at Fastest CAGR during Forecast Period
According to our new market research study on “Asthma Spacers Market to 2027 – US Analysis and Forecast – by Product and Distribution Channel,” the market is expected to reach US$ 702.27 million by 2027 from US$ 472.92 million in 2019; it is estimated to grow at a CAGR of 5.3% from 2020 to 2027. The report highlights trends prevailing in the US asthma spacers market and the drivers and restraints pertaining to the market growth.
Based on product, the US asthma spacers market is segmented into into aerochamber, optichamber, volumatic, and inspirease. The aerochamber segment is estimated to register the highest CAGR in the market during the forecast period. The growth of this segment is attributed to the increasing prevalence of respiratory conditions such as asthma and COPD in the US. Further, the easy availability of the product and increasing awareness about benefits of aerochambers are also anticipated to drive the segmental market growth.
The US asthma spacersmarket growth is mainly attributed to factors such as increasing prevalence of respiratory conditions and growing awareness regarding the benefits of spacers. However, increased risk of adverse effects due to unlicensed prescriptions restrains the growth of the market.
The COVID-19 pandemic has affected on the US asthma spacers market. It has disrupted the supply chain operations in the country. However, the healthcare authorities and government organizations in the US are focusing on spreading awareness about COVID-19 among asthmatic patients as they are highly vulnerable to other lung infections. Such awareness programs are likely to have positive impact on the adoption of asthma spacers due to precautionary measures, which will eventually drive the market up to certain extent.
Cipla Inc., PARI GmbH, Koninklijke Philips N.V., Lupin, HAAG-STREIT GROUP, LaboratoireProtecSom, Monaghan Medical Corporation, Koo Medical Equipment, Agaplastic, and Teleflex Incorporated are among the leading companies operating in the US asthma spacers market.
The Report Segments US Asthma Spacers Market as Follows:
- Retail Pharmacy
- Hospital Pharmacy
Contact Person: Sameer Joshi
Email Id: firstname.lastname@example.org